Reply: ‘Comments on Stromal disrupting effects of nab-paclitaxel in pancreatic cancer’

被引：0
|
作者：
R Alvarez
M Musteanu
E Garcia-Garcia
P P Lopez-Casas
D Megias
C Guerra
M Muñoz
Y Quijano
A Cubillo
J Rodriguez-Pascual
C Plaza
E de Vicente
S Prados
S Tabernero
M Barbacid
F Lopez-Rios
M Hidalgo
机构：
[1] Centro Integral Oncológico Clara Campal (CIOCC),
[2] Oña 10,undefined
[3] Spanish National Cancer Research Centre (CNIO),undefined
[4] Melchor Fernández Almagro 3,undefined
来源：
British Journal of Cancer | 2014年 / 111卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1677 / 1678
页数：1
相关论文
共 50 条
  • [1] Reply: 'Comments on Stromal disrupting effects of nab-paclitaxel in pancreatic cancer'
    Alvarez, R.
    Musteanu, M.
    Garcia-Garcia, E.
    Lopez-Casas, P. P.
    Megias, D.
    Guerra, C.
    Munoz, M.
    Quijano, Y.
    Cubillo, A.
    Rodriguez-Pascual, J.
    Plaza, C.
    de Vicente, E.
    Prados, S.
    Tabernero, S.
    Barbacid, M.
    Lopez-Rios, F.
    Hidalgo, M.
    BRITISH JOURNAL OF CANCER, 2014, 111 (08) : 1677 - 1678
  • [2] Stromal disrupting effects of nab-paclitaxel in pancreatic cancer
    Alvarez, R.
    Musteanu, M.
    Garcia-Garcia, E.
    Lopez-Casas, P. P.
    Megias, D.
    Guerra, C.
    Munoz, M.
    Quijano, Y.
    Cubillo, A.
    Rodriguez-Pascual, J.
    Plaza, C.
    de Vicente, E.
    Prados, S.
    Tabernero, S.
    Barbacid, M.
    Lopez-Rios, F.
    Hidalgo, M.
    BRITISH JOURNAL OF CANCER, 2013, 109 (04) : 926 - 933
  • [3] Stromal disrupting effects of nab-paclitaxel in pancreatic cancer
    R Alvarez
    M Musteanu
    E Garcia-Garcia
    P P Lopez-Casas
    D Megias
    C Guerra
    M Muñoz
    Y Quijano
    A Cubillo
    J Rodriguez-Pascual
    C Plaza
    E de Vicente
    S Prados
    S Tabernero
    M Barbacid
    F Lopez-Rios
    M Hidalgo
    British Journal of Cancer, 2013, 109 : 926 - 933
  • [4] nab-Paclitaxel for the treatment of pancreatic cancer
    Kim, George
    CANCER MANAGEMENT AND RESEARCH, 2017, 9 : 85 - 96
  • [5] Nab-paclitaxel shows promise in pancreatic cancer
    Baker, Holly
    LANCET ONCOLOGY, 2013, 14 (13): : E585 - E585
  • [6] Case report of nab-paclitaxel in metastatic pancreatic cancer
    Haslbauer F.
    memo - Magazine of European Medical Oncology, 2014, 7 (1) : 39 - 42
  • [7] Nab-Paclitaxel as new Therapeutic Option for Pancreatic Cancer
    Michl, P.
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2013, 51 (11): : 1329 - 1330
  • [8] Nab-paclitaxel: potential for the treatment of advanced pancreatic cancer
    Al-Hajeili, Marwan
    Azmi, Asfar S.
    Choi, Minsig
    ONCOTARGETS AND THERAPY, 2014, 7 : 187 - 192
  • [9] NAB-PACLITAXEL AND GEMCITABINE DECREASE CANCER-ASSOCIATED FIBROBLASTS THROUGH PANCREATIC STROMAL DEPLETION
    Miyashita, Tomoharu
    Tajima, Hidehiro
    Kitagawa, Hirohisa
    Makino, Isamu
    Ahmed, Ali K.
    Harmon, John W.
    Ohta, Tetsuo
    GASTROENTEROLOGY, 2017, 152 (05) : S1269 - S1269
  • [10] Clinical efficacy of nab-paclitaxel in patients with metastatic pancreatic cancer
    De Luca, Rossella
    Blasi, Livio
    Alu, Massimiliano
    Gristina, Valerio
    Cicero, Giuseppe
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 12 : 1769 - 1775
12345